Katagiri Hideki, Yoshikawa Kentaro, Lefor Alan Kawarai, Kubota Tadao, Mizokami Ken
Department of Surgery, Tokyo Bay Urayasu Ichikawa Medical Center, 3-4-32 Todaijima, Urayasu, Chiba 279-0001, Japan.
Department of Surgery, Jichi Medical University, 1-3311 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.
Case Rep Surg. 2016;2016:7013708. doi: 10.1155/2016/7013708. Epub 2016 Sep 21.
Preperitoneal hematomas are rare and can develop after surgery or trauma. A 74-year-old woman, receiving systemic anticoagulation, developed a massive preperitoneal hematoma after a subcutaneous injection of teriparatide using a 32-gauge, 4 mm needle. In this patient, there were two factors, the subcutaneous injection of teriparatide and systemic anticoagulation, associated with development of the hematoma. These two factors are especially significant, because they are widely used clinically. Although extremely rare, physicians must consider this potentially life-threatening complication after subcutaneous injections, especially in patients receiving anticoagulation.
腹膜前血肿罕见，可在手术或创伤后发生。一名74岁接受全身抗凝治疗的女性，使用32号4毫米针头皮下注射特立帕肽后发生了巨大的腹膜前血肿。在该患者中，皮下注射特立帕肽和全身抗凝这两个因素与血肿的发生有关。这两个因素尤为重要，因为它们在临床上广泛使用。尽管极为罕见，但医生在皮下注射后必须考虑这种潜在的危及生命的并发症，尤其是在接受抗凝治疗的患者中。
